Paul Goepfert, M.D.
Marnix E. Heersink School of Medicine Division of Infectious Diseases
Media Contact:
Anna Jones
Paul Goepfert, M.D.
Marnix E. Heersink School of Medicine Division of Infectious DiseasesPaul Goepfert, M.D., is the director of the Alabama Vaccine Research Clinic. His laboratory concentrates on understanding the immune correlates of protection against HIV disease progression with a focus on cell medicated immune responses. In 2020, Goepfert was a high-ranking member on the Johnson and Johnson COVID-19 vaccine research trial in North America.
Areas of Expertise:
- Infectious Diseases
- Vaccines and vaccine research
- COVID-19
Media Appearances:
- Why Americans shouldn't turn their noses up at Johnson & Johnson's vaccine, CNN
- FDA authorizes Johnson & Johnson’s single-shot coronavirus vaccine, adding to the nation’s arsenal against the pandemic, The Washington Post
- A future COVID-19 vaccine could be squirted up the nose. The nasal spray could stop transmission, especially in kids, Business Insider
- J&J vaccine could be a 'game changer.' Here's why a third option matters, NBC News